<DOC>
	<DOCNO>NCT00825656</DOCNO>
	<brief_summary>The purpose study demonstrate equivalence two homeopathic capsaicin contain nasal spray ( Sinol-M™ Sinol ) patient nasal congestion due allergic rhinitis .</brief_summary>
	<brief_title>Comparative Study Sinol Sinol-M Patients With Congestion Due Allergic Rhinitis</brief_title>
	<detailed_description>Sinol FDA register , capsaicin-based , over-the-counter homeopathic nasal spray use relief allergy sinus condition . It all-natural product patient use as-needed basis 12 time daily . Sinol available US since 2004 . In 2009 second generation product , Sinol-M launch . Sinol-M identical original formula also contain MucoAd MucoAd™ patent non-toxic , non-irritating , liquid polymer mucoadhesive carrier prolongs contact time drug mucosa , thus increase bioavailability . It load nearly pharmaceutical preparation deliver variety mucosal tissue . Reduced mucociliary clearance intranasally-applied drug desirable reduce naturally-occurring wash topically apply medication . The objective current Phase IV , randomize , double-blind , cross-over study , evaluate frequency use efficacy SINOL SINOL + MucoAd™ ( Sinol-M ) demonstrate non-inferiority Sinol-M versus exist product Sinol . Additionally , homeopathic drug support prospective clinical data belief among many mainstream healthcare practitioner , consumer product work . This study therefore provide opportunity demonstrate improve efficacy versus treatment ( run-in washout phase ) .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Willing participate indicate provide write informed consent 12 year age old , gender race Have positive skin prick and/or intradermal test currently prevalent allergen within past 5 year A history allergic rhinitis , least 2 year Have undergo washout medication could influence study Willing able make require study visit Able follow instruction record diary symptom . Free significant anatomic abnormality , infection , bleeding , mucosal ulceration nasal examination Have TNSS 4 12 average 7 day immediately prior V2 Have average individual score nasal congestion great equal 2 7 day immediately prior V2 . concurrent disease could interfere investigation evaluation study medication : rhinitis medicamentosa large obstructive nasal polyp anatomic nasal deformity could interfere participation study asthma , exception mild intermittent asthma congestion , opinion study investigator , could interfere successful nasal drug administration/absorption ( either nostril ) use systemic corticosteroid ( oral , parenteral , intravenous , rectal ) inhale ocular corticosteroid within last 30 day undergo allergy immunotherapy , unless stable dose regimen throughout course study Be use dermal potent superpotent topical corticosteroid systemic disorder could interfere evaluation study medication hypersensitivity study drug component thereof history drug alcohol abuse would interfere participation study history severe , unstable , uncontrolled cardiovascular , hepatic , renal and/or diseases/illnesses could expect interfere study upper low respiratory infection within 14 day Vist 2 acute sinusitis within 30 day Visit 2 history evidence nasolacrimal drainage system malfunction Be plan travel area significantly antigenically different substantial portion ( 48 hour ) give study week . participation investigational study within 30 day entry study concomitantly study chronic intermittent use prescription overthecounter ( OTC ) nasal spray study period</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Capsaicin</keyword>
	<keyword>Homeopathic</keyword>
	<keyword>Sinol</keyword>
	<keyword>Sinol-M</keyword>
</DOC>